Trials / Completed
CompletedNCT00772733
A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 936 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team
Conditions
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2008-10-15
- Last updated
- 2011-02-23
Locations
11 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00772733. Inclusion in this directory is not an endorsement.